5DX — Meta Health Income Statement
0.000.00%
Last trade - 00:00- SG$6.60m
- SG$8.57m
- SG$0.24m
Annual income statement for Meta Health, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 32.2 | 43 | 11.4 | 4.61 | 0.245 |
| Cost of Revenue | |||||
| Gross Profit | 15.7 | 20.5 | 1.86 | 0.825 | 0.19 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 33.7 | 41.3 | 18.5 | 7.65 | 1.16 |
| Operating Profit | -1.51 | 1.72 | -7.1 | -3.04 | -0.912 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.94 | 1.21 | -7.37 | -3.33 | -1.05 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.96 | 1.21 | -7.37 | -3.33 | -1.05 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.96 | 1.16 | -8.66 | -8.41 | -1.44 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.96 | 1.16 | -8.66 | -8.41 | -1.44 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | -0 | -0.011 | -0.005 | -0.001 |